CRO Transition & Rescue Solutions

• Go beyond just fixing immediate issues and get a proactive assessment of your data for regulatory compliance.Our experts conduct thorough regulatory reviews, identifying any gaps in compliance that could hinder your program’s success. MMS works to ensure that your clinical data aligns with global health authority requirements to reduce the risk of any delays or refusals to file. To date, MMS has experienced zero refusals to file in the 18+ years since inception.

Efficiently move your clinical trial to MMS, leveraging our expertise in managing the biometrics and regulatory activities needed to put your trial back on the right path.

We have a well-established playbook with defined processes for transitioning your clinical study with minimal disruptions. This is our “North Star” to mitigate any risks for you and ensure smooth continuity.

Streamline the transfer and management of your study’s data, ensuring that technical challenges are resolved quickly and with minimal disruption.

With cutting-edge tools like Datacise®, MMS can handle the technical challenges of transitioning your clinical study’s entire data infrastructure and processes. Using our in-house technology resources, we work to optimize for efficiency and compliance every step of the way.

Switching to a new CRO mid-study can be daunting, but our transition processes are built around minimizing risk and maximizing efficiency. Rest easy knowing that we ensure your trial stays on course, from database build to regulatory filings.

From robust transition processes to cutting-edge technology transitions and detailed regulatory gap analyses, we ensure that your trial continues smoothly, compliantly, and on time.